Loading…
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · second_quarter · Health Issues
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209) and the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $70,000
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Medicare/Medicaid
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Medicare/Medicaid
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Health Issues
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · first_quarter · Medicare/Medicaid
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R.5745 - COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Health Issues
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE